EU project to launch five RFID pilot tests

Following a year of research and development, the EU-funded BRIDGE project is now preparing five pilots to test Electronic Product Code (EPC) and Radio Frequency Identification (RFID) technologies.

The pilots, scheduled to start in September, will test RFID across several sectors of industry including retail, pharmaceutical, manufacturing, distribution and logistics, and services.

The Electronic Product Code (EPC) is a family of coding schemes created to succeed the bar code. It was created as a low-cost method of tracking goods using RFID technology. RFID is a method of identifying unique items using radio waves. Typically, a reader communicates with a tag, which holds digital information in a microchip.

BRIDGE (Building Radio frequency IDentification solutions for the Global Environment) is a three-year €7.5 million project funded under the EU's Sixth Framework Programme (FP6). It is made up of a consortium of 30 partners from the worlds of industry and research.

BRIDGE was created to research, develop and implement tools enabling RFID and EPCglobal applications, as well as to drive the acceptance of EPCglobal standards in Europe.

The first pilot to go live will test the use of EPC second-generation technology to track pallets of pharmaceutical products as they move through the supply chain, from the manufacturers through distributor networks and on to hospitals and pharmacies.

"The purpose of the pilot is to use RFID to know where the goods come from, and where they are at any given moment," said Henri Barthel, the coordinator of the BRIDGE project. "With RFID, the idea is that the technology can help companies manage the supply chain in a much more accurate and efficient manner."

The pilot will aim to trace a number of products, identified at the carton and pallet levels using EPC RFID tags and 2-D bar-code labels. According to the organisers, deploying this 'hybrid environment' of RFID and bar-coding will afford them the chance to discover the pros and cons of each technology. In addition to RFID tags and 2-D bar-code labels, the pilot will incorporate a network-based system allowing the participants in the project to store, access and analyse all data collected during the experiment.

Ultimately, the objective of the pilot will be to increase the safety of patients by improving the traceability of pharmaceutical products and certifying the pedigree or authenticity of these as they move from the manufacturer to the final user.

Another pilot will be in the retail sector where BRIDGE will test the use of second generation EPC RFID to track cartons and pallets of clothing from the point of manufacture to the store. The pilot will track the goods as they move across the supply chain, but could also include novel in-store applications such as using RFID tags to identify individual garments, and installing RFID interrogators in dressing rooms so shoppers could obtain detailed product information about the items they are trying on, such as sizes, prices and availability.

Lastly, three more similar pilots will take place in food manufacturing processes, reusable assets and products in-service. The results of all five pilots will be made available by the project as it seeks to promote the uptake of standardised EPC and RFID technology for use in global supply chains.

"Since its inception, RFID has been hailed as the panacea for a more sophisticated and efficient global supply chain," said Mr Barthel. "The BRIDGE project will transform RFID from being an identification technology into providing an EPCglobal based product information network."

For further information, please visit:
http://www.bridge-project.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...